Researchers Report Kilogram-Scale Synthesis of Cholesterol Drug Enlicitide
A Science study describes a new production method for enlicitide, a peptide in Phase 3 trials for lowering LDL cholesterol. The route uses engineered enzymes and crystallization steps to reduce reaction count and raise yield.
finance.yahoo.comResearchers published a kilogram-scale synthesis method for enlicitide in Science. The peptide is currently in a Phase 3 clinical trial for lowering low-density lipoprotein cholesterol. The reported route relies on engineered enzymes and crystallization of key intermediates.
It reduces the number of reaction steps and improves overall yield compared with prior approaches. A SciencePerspective accompanying the paper outlines the technical details of the enzymatic and crystallization sequence.
Key Facts
Potential Impact
- 01
Pharmaceutical manufacturers may evaluate the enzymatic route for larger-scale production.
- 02
Further process optimization studies could follow publication of the enzymatic sequence.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…